Lemaitre Vascular (NSDQ:LMAT) posted first-quarter results that beat the revenue consensus on Wall Street and missed earnings estimates.
The Burlington, Massachusetts-based vascular device company reported profits of $6 million, or 27¢ per share on sales of $39.6 million for the three months ended March 31, for a bottom-line gain of 1.8% on sales growth of 10.25% compared with Q1 2021.
Get the full story on our sister site, Medical Tubing + Extrusion.